Cory Abate-Shen on Bladder Cancer Modeling

Cory Abate-Shen, PhD
Published: Monday, Jan 11, 2016



Cory Abate-Shen, PhD, research faculty, Columbia Urology, Columbia University Medical Center, discusses the challenges of bladder cancer modeling.

In order to develop mouse models, it is necessary to know where the tumor originates. However, this is not currently well understood in bladder cancer, says Abate-Shen.

Researchers are working to understand the key alterations that contribute to bladder cancer tumors. Recent advancements in genomic analysis have given researchers more tools, and it is now understood that P53 is a key player in bladder cancer, says Abate-Shen.


Cory Abate-Shen, PhD, research faculty, Columbia Urology, Columbia University Medical Center, discusses the challenges of bladder cancer modeling.

In order to develop mouse models, it is necessary to know where the tumor originates. However, this is not currently well understood in bladder cancer, says Abate-Shen.

Researchers are working to understand the key alterations that contribute to bladder cancer tumors. Recent advancements in genomic analysis have given researchers more tools, and it is now understood that P53 is a key player in bladder cancer, says Abate-Shen.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x